Picture of HBM Healthcare Investments AG logo

HBMN — HBM Healthcare Investments AG News Story

0.000.00%
ch flag iconLast trade - 00:00
FinancialsBalancedMid CapSuper Stock

Brief: HBM Healthcare Investments: Gilead Sciences To Acquire HBM Portfolio Company Immunomedics

Sept 14 (Reuters) - HBM Healthcare Investments AG  HBMN.S :
    * GILEAD SCIENCES TO ACQUIRE HBM PORTFOLIO COMPANY
IMMUNOMEDICS
    * GILEAD WILL ACQUIRE IMMUNOMEDICS FOR USD 88.00 PER SHARE
IN
CASH.
    * ANTICIPATED TO CLOSE DURING Q4 OF 2020

Source text for Eikon:  ID:nTEN8cd9ba 
Further company coverage:  HBMN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on HBM Healthcare Investments AG

See all news